Back to results
US 2013/0259841 A1Published application
Mesenchymal Stem Cells Expressing TNF-alpha Receptors
AssigneeOsiris Therapeutics, Inc.
InventorsAlla Danilkovitch, Diane Carter, Alicia Tyrell, Simon Bubnic, Michelle Marcelino, Rodney Monroy
Life of this patent
Estimating the term…
Abstract
Mesenchymal stem cells which express TNF-α receptor Type I in an amount of at least 13 pg/106 cells. Such mesenchymal stem cells inhibit the proliferation of lymphocytes and may be employed, in particular, in the treatment of graft-versus-host disease.
Claims5
A composition comprising mesenchymal stem cells wherein said mesenchymal stem cells express TNF-α receptor Type I in an amount of at least 13 pg/106 cells.
Dependencies are inferred from the claim text.